Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
---|---|---|---|---|---|---|---|---|---|---|---|
AKRO | Akero Therapeutics, Inc. | Rolph Timothy | Chief Scientific Officer | Mar 13, 2024 | Sale | $28.33 | 619 | 17,536 | 182,558 | Mar 15, 2024, 04:42 PM | |
AKRO | Akero Therapeutics, Inc. | Rolph Timothy | Chief Scientific Officer | Dec 14, 2023 | Sale | $20.76 | 514 | 10,671 | 182,672 | Dec 18, 2023, 08:29 PM | |
AKRO | Akero Therapeutics, Inc. | Rolph Timothy | Chief Scientific Officer | Sep 13, 2023 | Sale | $50.34 | 531 | 26,731 | 150,689 | Sep 25, 2023, 08:30 PM | |
AKRO | Akero Therapeutics, Inc. | Rolph Timothy | Chief Scientific Officer | Jun 16, 2023 | Sale | $36.45 | 118,200 | 4,308,466 | 229,420 | Jun 21, 2023, 05:46 PM | |
AKRO | Akero Therapeutics, Inc. | Rolph Timothy | Chief Scientific Officer | Jun 13, 2023 | Sale | $55.16 | 509 | 28,076 | 189,420 | Jun 15, 2023, 09:35 PM | |
AKRO | Akero Therapeutics, Inc. | Rolph Timothy | Chief Scientific Officer | Mar 10, 2023 | Option Exercise | $43.47 | 603 | 26,212 | 189,929 | Mar 14, 2023, 04:19 PM | |
AKRO | Akero Therapeutics, Inc. | Rolph Timothy | Chief Scientific Officer | Dec 28, 2022 | Option Exercise | $39.18 | 3,400 | 133,201 | 204,732 | Dec 30, 2022, 04:26 PM | |
AKRO | Akero Therapeutics, Inc. | Rolph Timothy | Chief Scientific Officer | Dec 29, 2022 | Sale | $44.74 | 28,132 | 1,258,702 | 210,848 | Dec 30, 2022, 04:26 PM | |
AKRO | Akero Therapeutics, Inc. | Rolph Timothy | Chief Scientific Officer | Nov 16, 2022 | Sale | $45.47 | 3,947 | 179,464 | 183,937 | Nov 16, 2022, 07:15 PM | |
AKRO | Akero Therapeutics, Inc. | Rolph Timothy | Chief Scientific Officer | Nov 15, 2022 | Sale | $45.04 | 3,138 | 141,343 | 187,784 | Nov 16, 2022, 07:15 PM | |
AKRO | Akero Therapeutics, Inc. | Rolph Timothy | Chief Scientific Officer | Oct 25, 2022 | Option Exercise | $28.25 | 20,653 | 583,465 | 206,337 | Oct 27, 2022, 09:27 PM | |
AKRO | Akero Therapeutics, Inc. | Rolph Timothy | Chief Scientific Officer | Oct 26, 2022 | Sale | $45.03 | 4,762 | 214,433 | 190,922 | Oct 27, 2022, 09:27 PM | |
AKRO | Akero Therapeutics, Inc. | Rolph Timothy | Chief Scientific Officer | Sep 13, 2022 | Option Exercise | $22.16 | 32,500 | 720,150 | 256,337 | Oct 27, 2022, 09:23 PM | |
AKRO | Akero Therapeutics, Inc. | Rolph Timothy | Chief Scientific Officer | Oct 06, 2022 | Option Exercise | $33.69 | 32,500 | 1,094,925 | 208,837 | Oct 07, 2022, 06:00 PM | |
AKRO | Akero Therapeutics, Inc. | Rolph Timothy | Chief Scientific Officer | Sep 30, 2022 | Sale | $27.71 | 65,000 | 1,800,989 | 243,837 | Oct 04, 2022, 08:57 PM | |
AKRO | Akero Therapeutics, Inc. | Rolph Timothy | Chief Scientific Officer | Sep 13, 2022 | Sale | $29.18 | 22,500 | 656,550 | 223,837 | Sep 15, 2022, 07:56 PM | |
AKRO | Akero Therapeutics, Inc. | Rolph Timothy | Chief Scientific Officer | Jun 30, 2021 | Option Exercise | $21.09 | 1,007 | 21,238 | 245,185 | Sep 13, 2022, 09:14 PM | |
AKRO | Akero Therapeutics, Inc. | Rolph Timothy | Chief Scientific Officer | Jun 30, 2022 | Option Exercise | $8.03 | 1,152 | 9,251 | 246,337 | Sep 13, 2022, 09:14 PM | |
AKRO | Akero Therapeutics, Inc. | Rolph Timothy | Chief Scientific Officer | Jun 30, 2020 | Option Exercise | $17.07 | 1,245 | 21,250 | 244,178 | Dec 09, 2020, 08:49 PM | |
AKRO | Akero Therapeutics, Inc. | Rolph Timothy | Chief Scientific Officer | Mar 12, 2020 | Option Exercise | $0.61 | 50,024 | 30,515 | 242,933 | Mar 13, 2020, 07:04 PM |